— Know what they know.
Not Investment Advice
Also trades as: AVE.AX (ASX) · $vol 0M

AVEFF Earnings

Avecho Biotechnology Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -10.0% 5Y: -10.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $17.4M mcap · 3.18B float · 0.0062% daily turnover · Short 100% of daily vol
Last Earnings 2026-08-24
EPS
A$-0.00 (US$-0.00)
▼ Miss +0.0%
Revenue
A$41K ($29K)
▲ Beat +0.0%

Estimate vs Actual

Earnings Surprise History

0/17
EPS Beats
0/17
Revenue Beats
0%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2027-12-31 A$-0.00 A$-0.00 — A$2,153,012 A$2,147,153
2026-10-02 annual 2028-12-31 A$0.00 A$0.00 — A$6,181,228 A$6,164,407
2026-10-02 annual 2026-12-31 A$-0.00 A$-0.00 — A$2,222,464 A$2,216,416
2026-10-01 annual 2027-12-31 A$-0.00 A$-0.00 — A$2,175,270 A$2,153,012
2026-10-01 annual 2028-12-31 A$0.00 A$0.00 — A$6,245,130 A$6,181,228
2026-10-01 annual 2026-12-31 A$-0.00 A$-0.00 — A$2,245,440 A$2,222,464
2026-09-29 annual 2026-12-31 A$-0.00 A$-0.00 — A$2,247,360 A$2,245,440
2026-09-29 annual 2027-12-31 A$-0.00 A$-0.00 — A$2,177,130 A$2,175,270
2026-09-29 annual 2028-12-31 A$0.00 A$0.00 — A$6,250,470 A$6,245,130
2026-09-28 annual 2026-12-31 A$-0.00 A$-0.00 — A$2,274,528 A$2,247,360
2026-09-28 annual 2027-12-31 A$-0.00 A$-0.00 — A$2,203,449 A$2,177,130
2026-09-28 annual 2028-12-31 A$0.00 A$0.00 — A$6,326,031 A$6,250,470
2026-09-21 annual 2027-12-31 A$-0.00 A$-0.00 — A$2,212,439 A$2,203,449
2026-09-21 annual 2028-12-31 A$0.00 A$0.00 — A$6,351,841 A$6,326,031
2026-09-21 annual 2026-12-31 A$-0.00 A$-0.00 — A$2,283,808 A$2,274,528
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms